David C. Myles - Net Worth and Insider Trading

David C. Myles Net Worth

The estimated net worth of David C. Myles is at least $9 Million dollars as of 2024-06-19. David C. Myles is the CH. DISCOV. & NON-CLIN DEV OFF of Olema Pharmaceuticals inc and owns about 728,945 shares of Olema Pharmaceuticals inc (OLMA) stock worth over $9 Million. Details can be seen in David C. Myles's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David C. Myles has not made any transactions after 2023-11-22 and currently still holds the listed stock(s).

Transaction Summary of David C. Myles

To

David C. Myles Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David C. Myles owns 1 companies in total, including Olema Pharmaceuticals inc (OLMA) .

Click here to see the complete history of David C. Myles’s form 4 insider trades.

Insider Ownership Summary of David C. Myles

Ticker Comapny Transaction Date Type of Owner
OLMA Olema Pharmaceuticals inc 2023-11-22 Chief Development Officer

David C. Myles Latest Holdings Summary

David C. Myles currently owns a total of 1 stock. David C. Myles owns 728,945 shares of Olema Pharmaceuticals inc (OLMA) as of November 22, 2023, with a value of $9 Million.

Latest Holdings of David C. Myles

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OLMA Olema Pharmaceuticals inc 2023-11-22 728,945 12.00 8,747,340

Holding Weightings of David C. Myles


David C. Myles Form 4 Trading Tracker

According to the SEC Form 4 filings, David C. Myles has made a total of 5 transactions in Olema Pharmaceuticals inc (OLMA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Olema Pharmaceuticals inc is the sale of 13,629 shares on November 22, 2023, which brought David C. Myles around $196,258.

Insider Trading History of David C. Myles

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David C. Myles Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David C. Myles Ownership Network

Ownership Network List of David C. Myles

No Data

Ownership Network Relation of David C. Myles

Insider Network Chart

David C. Myles Owned Company Details

What does Olema Pharmaceuticals inc do?

Who are the key executives at Olema Pharmaceuticals inc?

David C. Myles is the Chief Development Officer of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , 10 percent owner Paradigm Biocapital Advisors Lp , and director & President and CEO Sean Bohen .

Olema Pharmaceuticals inc (OLMA) Insider Trades Summary

Over the past 18 months, David C. Myles made 4 insider transaction in Olema Pharmaceuticals inc (OLMA) with a net sale of 44,370. Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 308,181 shares made by Cyrus Harmon , a net sale of 535,000 shares made by G. Walmsley Graham , and a net sale of 8,742 shares made by Kovacs Shane William Charles .

In summary, during the past 3 months, insiders sold 1,240,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 1,240,000 shares. During the past 18 months, 1,618,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 637,858 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Olema Pharmaceuticals inc Insider Transactions

No Available Data

David C. Myles Mailing Address

Above is the net worth, insider trading, and ownership report for David C. Myles. You might contact David C. Myles via mailing address: C/o Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor, San Francisco Ca 94107.

Discussions on David C. Myles

No discussions yet.